A comparison of treosulfan and carboplatin in patients with ovarian cancer not suitable for treatment with cisplatin.

Trial Profile

A comparison of treosulfan and carboplatin in patients with ovarian cancer not suitable for treatment with cisplatin.

Discontinued
Phase of Trial: Phase II

Latest Information Update: 21 Apr 2014

At a glance

  • Drugs Carboplatin (Primary) ; Treosulfan (Primary)
  • Indications Ovarian cancer
  • Focus Therapeutic Use
  • Most Recent Events

    • 02 Feb 2012 Planned end date (15 Jul 1998) added as reported by ISRCTN: Current Controlled Trials.
    • 02 Feb 2012 Status changed from completed to discontinued as reported by ISRCTN: Current Controlled Trials.
    • 30 Nov 2005 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top